Thoughts From The Home Edit's Clea Shearer
"In 2022, when I was diagnosed with HR+, HER2– node-positive early breast cancer, I received an unexpected superpower: the power to look positively toward the future. With my family and care team by my side, I underwent a double mastectomy followed by months of chemotherapy and radiation. After active treatment, I started taking Verzenio with hormone therapy. I'm working with Lilly, the makers of Verzenio, to help other women like me learn what they can about early breast cancer and the importance of exploring treatment options. It's a mission and a journey that I personally will be on forever, and my plan is to make as big an impact as I can."
XO
Learn more about Verzenio for Early Breast Cancer
Reducing her risk of recurrence
After she finished active treatment, Clea talked with her care team and family about what was next. Together, they decided taking Verzenio with hormone therapy was a great option for her. Knowing that by taking Verzenio her risk of recurrence may be reduced, Clea gained the peace of mind she needed to focus on what matters most – her family, friends, and The Home Edit community.
For women with HR+, HER2–, node-positive early breast cancer with a high chance of returning, as determined by your healthcare provider, Verzenio + hormone therapy showed a 35% reduction in the risk of cancer returning, compared with hormone therapy alone.
In a study, 85.5% of people taking Verzenio + hormone therapy were living without their cancer returning vs 78.6% taking hormone therapy alone. Data was assessed at 48 months; the study is ongoing to see if there is a survival benefit. Individual results may vary.
What makes Verzenio different?SELECT SAFETY INFORMATION
Warnings - Verzenio may cause serious side effects, including:
Diarrhea is common with Verzenio, may sometimes be severe and may cause dehydration or infection. The most common time to develop diarrhea is during the first month of Verzenio treatment. If you develop diarrhea during treatment with Verzenio, your healthcare provider may tell you to temporarily stop taking it, stop your treatment, or decrease your dose. If you have any loose stools, start taking an antidiarrheal medicine (such as loperamide), drink more fluids, and tell your healthcare provider right away.
Moving forward with Verzenio
Following her diagnosis, Clea found that her gratitude and appreciation for life reached new levels. Now, Clea eagerly anticipates the future, with thrilling projects for The Home Edit on the horizon and many joyful family moments to come. She is also looking forward to dedicating time to one important mission: working in partnership with Lilly and Verzenio to raise awareness for HR+, HER2– high-risk early breast cancer. This partnership will encourage more people to talk with their doctors about recurrence risk factors and available treatment options.
Talk to your doctor about whether Verzenio is right for you
About The Home Edit's Clea Shearer
Clea Shearer is a Nashville-based home organizing expert and Co-Founder of The Home Edit alongside her best friend Joanna Teplin. The Home Edit was founded with the goal of reinventing traditional organizing and merging it with design. Since then, it has grown into a global media and organization company with a social following of over 9 million people and organizing teams in 7 cities across the country. The Home Edit has become a household name with three New York Times' bestselling books, an Emmy®-nominated Netflix® show, Get Organized with The Home Edit, and a successful line of organizational products sold in stores in over 31 countries. Their work continues to reach a wide audience with the upcoming relaunch of ABC's Extreme Makeover: Home Edition. In 2022, Clea was diagnosed with breast cancer after finding a lump in her breast during a self-exam. After a double mastectomy and active treatment, Clea began taking Verzenio with hormone therapy. Inspired by her own cancer journey, Clea has made it her mission to help raise awareness around breast cancer to help women like her feel less alone.